Cargando…
Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
BACKGROUND: Statin may confer anticancer effect. However, the association between statin and risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) or hepatitis C (HCV) virus infection remains inconsistent according to results of previous studies. A meta-analysis was perform...
Autores principales: | Li, Xiaofei, Sheng, Lina, Liu, Liwen, Hu, Yongtao, Chen, Yongxin, Lou, Lianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147033/ https://www.ncbi.nlm.nih.gov/pubmed/32272891 http://dx.doi.org/10.1186/s12876-020-01222-1 |
Ejemplares similares
-
Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020) -
H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022) -
Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
por: Li, Xiaofei, et al.
Publicado: (2021) -
Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010) -
Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies
por: Chen, Yongxin, et al.
Publicado: (2018)